Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Sarcoma 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Specimen Handling 14 Magnetic Resonance Spectroscopy 14 Doxorubicin 11 Cyclophosphamide 11 Biopsy 9 Radiation 8 atezolizumab 7 Temozolomide 7 X-Rays 6 Vincristine 6 Nivolumab 6 Etoposide 6 Bevacizumab 6 liposomal doxorubicin 5 fludarabine 5 cabozantinib 5 Sirolimus 5 Radiotherapy 5 Phantoms, Imaging 5 Irinotecan 5 Immunoglobulin G 5 Ifosfamide 5 Disulfides 5 pembrolizumab 4 Nuclear Medicine Department, Hospital 4 temsirolimus 3 palbociclib 3 olaparib 3 fludarabine phosphate 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

pemigatinib × Sarcoma × 30 days × Clear all

NCT07434843 2026-05-22

PEMIGIST

Dana-Farber Cancer Institute

Phase 2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡